Clinical Study

Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial

Table 3

Patient-demonstrated knowledge of the medication regimen before and after intervention: Medtable versus usual care.

ā€‰TimeMedtableUsual careUnadjusted intervention effect (ITT)Adjusted intervention effect (ITT)
ā€‰Mean (SD)Mean (SD)OR (95% CI) valueOR (95% CI) value

Combined demonstration knowledge of the regimen for all 4 questionsBaseline, preintervention0.86 (0.15)0.85 (0.16)1.03 (0.88, 1.20)0.73201.03 (0.88, 1.21)0.7402
Immediate, postintervention0.86 (0.15)0.85 (0.15)1.08 (0.92, 1.26)0.35601.09 (0.93, 1.29)0.2799
Month 30.86 (0.15)0.85 (0.15)1.07 (0.91, 1.26)0.39161.06 (0.90, 1.25)0.4814
Month 60.86 (0.14)0.86 (0.14)1.08 (0.92, 1.27)0.36761.06 (0.90, 1.26)0.4763

When compared to the label, the patient demonstrates correct number of pills per doseBaseline, preintervention0.895 (0.131)0.90 (0.13)0.97 (0.81, 1.17)0.77280.99 (0.82, 1.19)0.8971
Immediate, postintervention0.9 (0.131)0.90 (0.13)1.05 (0.87, 1.26)0.62741.09 (0.90, 1.31)0.3880
Month 30.90 (0.134)0.89 (0.13)0.95 (0.79, 1.14)0.55490.95 (0.79, 1.14)0.5925
Month 60.902 (0.128)0.91 (0.119)0.99 (0.82, 1.20)0.95531.00 (0.83, 1.22)0.9839

When compared to the label, the patient demonstrates correct number of doses per dayBaseline, preintervention0.89 (0.13)0.88 (0.14)1.03 (0.87, 1.23)0.72621.03 (0.86, 1.24)0.7093
Immediate, postintervention0.89 (0.126)0.88 (0.14)1.10 (0.92, 1.32)0.28231.12 (0.93, 1.34)0.2448
Month 30.90 (0.129)0.88 (0.139)1.19 (0.99, 1.42)0.06221.18 (0.98, 1.42)0.0758
Month 60.901 (0.127)0.90 (0.126)1.12 (0.93, 1.35)0.22431.10 (0.91, 1.33)0.3228

The patient demonstrates correct number of pills each day in totalBaseline, preintervention0.87 (0.143)0.87 (0.147)1.04 (0.88, 1.23)0.62581.04 (0.88, 1.23)0.6504
Immediate, postintervention0.878 (0.140)0.87 (0.14)1.06 (0.90, 1.25)0.50461.07 (0.90, 1.27)0.4345
Month 30.875 (0.136)0.87 (0.14)1.07 (0.91, 1.27)0.40201.06 (0.90, 1.26)0.4883
Month 60.880 (0.134)0.88 (0.135)1.07 (0.90, 1.26)0.46231.05 (0.88, 1.25)0.5656

The patient demonstrates correct amount of time (spacing) between dosesBaseline, preintervention0.89 (0.130)0.88 (0.147)1.02 (0.86, 1.21)0.83401.02 (0.85, 1.22)0.8082
Immediate, postintervention0.90 (0.126)0.88 (0.14)1.09 (0.91, 1.30)0.33011.11 (0.93, 1.33)0.2611
Month 30.90 (0.130)0.88 (0.14)1.17 (0.98, 1.40)0.08551.17 (0.97, 1.40)0.1104
Month 60.9 (0.127)0.89 (0.126)1.12 (0.93, 1.34)0.24571.09 (0.91, 1.32)0.3525

ITT: intention-to-treat analysis. Covariates used for adjustment were health literacy (REALM), Letter Comparison test, Pattern Comparison test, diabetes mellitus knowledge, diabetes self-care: diet, diabetes self-care: exercise, diabetes self-care: glucose testing, years with diabetes mellitus, Comorbidity Index, general health, age, gender, race, patient education, research site, and Medication Regimen Complexity Index.